Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Removed the core disease keyword 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics'. This reduces contextual labeling and discoverability for users seeking information about the study and the disease.
    Difference
    0.1%
    Check dated 2026-02-18T04:00:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 label and removed the prior Revision: v3.4.1 notice. The government funding/operating status notice was deleted, with no changes to trial data, eligibility criteria, or study locations.
    Difference
    0.3%
    Check dated 2026-02-11T01:32:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH operations status, plus related topics including MedlinePlus Genetics; updated the revision to v3.4.1 and removed v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:28:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page includes minor UI/text updates such as a Show glossary option, updated QC-related labels (Last Update Submitted that Met QC Criteria) and footer references (No FEAR Act Data) with Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T23:38:38.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics in the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T00:27:23.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    A new site revision label Revision: v3.3.4 was added, and related-topic tags such as Multiple Myeloma and MedlinePlus Genetics were removed (along with Revision: v3.3.3). The core study content and details remain unchanged.
    Difference
    0.2%
    Check dated 2026-01-14T01:29:40.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.